TPG Capital names industry veteran Sun to head China business

Wangjing, China. Photo: Pixabay

TPG, a leading global alternative asset firm, has appointed Chang Sun as managing partner of its China business, according to a statement. His appointment has taken place with immediate effect.

In his role as managing partner at TPG, Sun will oversee the company’s investment activities in China across TPG Capital Asia, TPG Growth, and The Rise Fund.

He has also been associated with Warburg Pincus for 20 years in China but in 2015, Sun quit to start his own agriculture and impact investment firm, Black Soil Group Ltd.

“Chang’s appointment is an important addition to TPG’s strong and growing regional leadership team, and further underscores the strategic importance of Greater China to the firm as we continue to grow and evolve. We look forward to leveraging his local experience and insights as we continue to build our network and presence in the region,” said Jon Winkelried, co-CEO of TPG.

Sun has over two-and-a-half decades of experience investing in China. He has also been a significant part of China’s investment community. He founded two industry trade organizations – the China Venture Capital and Private Equity Association (CVCA) and the China Real Estate Developers and Investors’ Association (CREDIA) – where he currently serves as honorary chairman and executive vice-chairman, respectively.

On his appointment, Sun said, “I am attracted to TPG’s global network, flexible approach, social impact investing platform, and rich experience investing in quality businesses around the world. TPG’s entrepreneurial spirit and innovative approach are unique among global alternative asset firms. I look forward to partnering with TPG’s senior management and the rest of the Asia team to continue to build its franchise in the region.”

Last week, investment firm Jeneration Capital Management appointed Tony Zhang as partner who will join the team of buy-side professionals focused on direct private investments.

Also read:

PE firm TPG acquires majority stake in Taiwan clinical research firm OPC

India: TPG Capital’s stake sale in Healthium Medtech draws 4 bidders